EGI
CLBT icon

EAM Global Investors’s Cellebrite CLBT Stock Holding History

EAM Global Investors’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-137,662
Closed -$2.67M – 93
2025
Q1 		$2.67M Sell
137,662
-109,328
-44% -$2.3M 0.73% 75
2024
Q4 		$5.44M Buy
246,990
+201,991
+449% +$3.89M 0.98% 27
2024
Q3 		$758K Sell
44,999
-22,326
-33% -$331K 0.15% 98
2024
Q2 		$805K Sell
67,325
-7,010
-9% -$78.3K 0.18% 87
2024
Q1 		$824K Hold
74,335
– – 0.19% 87
2023
Q4 		$644K Sell
74,335
-33,161
-31% -$258K 0.16% 97
2023
Q3 		$822K Sell
107,496
-12,915
-11% -$96.9K 0.22% 96
2023
Q2 		$867K Buy
+120,411
New +$702K 0.25% 81

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
AE
Axon Enterprise Scottsdale, Arizona $19.1M AUM 8.75% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EAM Global Investors's CLBT Position: Q2 2025 in Review

EAM Global Investors sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 137,662 shares — an estimated $2.67M sold.

EAM Global Investors first reported a position in CLBT in Q2 2023 and held it in 8 quarters. The position peaked at $5.44M in Q4 2024. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

  • EAM Global Investors reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
  • EAM Global Investors sold 137,662 Cellebrite shares in Q2 2025, an estimated $2.67M.
  • EAM Global Investors first reported a position in Cellebrite in Q2 2023 and held it in 8 quarters.
  • EAM Global Investors's Cellebrite position peaked at $5.44M in Q4 2024.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on EAM Global Investors's 13F filing for Q2 2025, filed 12 Aug 2025.